Microbot Medical, the developer of the Liberty endovascular robotic surgical system, is building on the momentum from the positive results of its good laboratory practices (GLP) pre-clinical study. The company is adding a clinical research associate to support its pending investigational device exemption, or IDE, submission to commence its … [Read more...] about Microbot Medical expands U.S. operations to prep for first in-human clinical study
Microbot Medical
Microbot Medical is a step closer to an FDA IDE submission
Microbot Medical today announced the successful completion of its pivotal pre-clinical study of its Liberty endovascular robotic surgical system. The study, performed under good laboratory practice (GLP) and essential for the company's investigational device exemption (IDE) submission, took place under rigorous FDA guidelines. The study involved … [Read more...] about Microbot Medical is a step closer to an FDA IDE submission